Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress

被引:43
|
作者
Cookson, MR
Menzies, FM
Manning, P
Eggett, CJ
Figlewicz, DA
McNeil, CJ
Shaw, PJ
机构
[1] Univ Sheffield, Sch Med, Dept Neurol, Acad Neurol Unit, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Newcastle Upon Tyne, Dept Clin Biochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Rochester, Dept Neurol & Neurobiol & Anat, Rochester, NY 14627 USA
关键词
amyotrophic lateral sclerosis; SOD1; mutations; nitric oxide; superoxide; neuroprotection;
D O I
10.1080/146608202760196048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The exact molecular mechanisms by which mutations in Cu/Zn superoxide dismutase (SOD1) cause motor neuron injury remain incompletely understood, though a body of evidence suggests that the mutant protein exerts a cell-specific toxic gain of function. The role of nitric oxide (NO) in SOD1-related motor neuron injury has been particularly controversial. Theoretically, there are arguments to suggest that NO may exert an important role in motor neuron injury, but there is relatively little direct experimental support for this hypothesis. Objectives: The present study aimed to examine further the potential role for NO in motor neuron injury caused by mutant SOD1. Method: We have generated a cellular model of familial amyotrophic lateral sclerosis (ALS) by stably transfecting NSC34 cells with one of three mutant forms of SOD1 (G93A, G37R, I113T). In the presence of mutant SOD1, NSC34 cells show increased cell death following oxidative stress induced by serum withdrawal. This model of motor neuron death involves cellular release of superoxide and NO radicals, which were directly measured in real time using microelectrode biosensors. Results: The expression of both normal and mutant SOD1 decreased the measured extracellular superoxide release, but had divergent effects on the measured release of NO. Normal SOD1 increased the measured NO release, whereas cells expressing mutant SOD1 released less NO. Co-administration of two different nitric oxide synthase inhibitors (L-NAME and L-N-methyl arginine) did show some neuroprotective effect, but this was only partial, and the effect was more marked using nuclear integrity as a measure of cell viability, rather than MTT conversion. Cells expressing mutant SOD1 were, however, more sensitive to toxicity induced by extrinsic exposure to NO, using a slow-release NO donor. Conclusion: NO is likely to contribute to motor neuron injury, but this does not fully account for all the cellular toxic effects of mutant SOD1.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 50 条
  • [31] Modification of Superoxide Dismutase 1 (SOD1) Properties by a GFP Tag - Implications for Research into Amyotrophic Lateral Sclerosis (ALS)
    Stevens, James C.
    Chia, Ruth
    Hendriks, William T.
    Bros-Facer, Virginie
    van Minnen, Jan
    Martin, Joanne E.
    Jackson, Graham S.
    Greensmith, Linda
    Schiavo, Giampietro
    Fisher, Elizabeth M. C.
    PLOS ONE, 2010, 5 (03): : A8 - A17
  • [32] Molecular Analyses of the Cu/Zn Superoxide Dismutase Gene in Patients with Familial Amyotrophic Lateral Sclerosis (ALS) in Japan
    Masashi Aoki
    Koji Abe
    Yasuto Itoyama
    Cellular and Molecular Neurobiology, 1998, 18 (6) : 639 - 647
  • [33] Molecular analyses of the Cu/Zn superoxide dismutase gene in patients with familial amyotrophic lateral sclerosis (ALS) in Japan
    Aoki, M
    Abe, K
    Itoyama, Y
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1998, 18 (06) : 639 - 647
  • [34] Non-native Soluble Oligomers of Cu/Zn Superoxide Dismutase (SOD1) Contain a Conformational Epitope Linked to Cytotoxicity in Amyotrophic Lateral Sclerosis (ALS)
    Redler, Rachel L.
    Fee, Lanette
    Fay, James M.
    Caplow, Michael
    Dokholyan, Nikolay V.
    BIOCHEMISTRY, 2014, 53 (14) : 2423 - 2432
  • [35] New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes
    Kato, S
    Takikawa, M
    Nakashima, K
    Hirano, A
    Cleveland, DW
    Kusaka, H
    Shibata, N
    Kato, M
    Nakano, I
    Ohama, E
    AMYOTROPHIC LATERAL SCLEROSIS, 2000, 1 (03): : 163 - 184
  • [36] Identification of a novel mutation in Cu/Zn superoxide dismutase gene associated with familial amyotrophic lateral sclerosis
    Naini, A
    Musumeci, O
    Hayes, L
    Pallotti, F
    Del Bene, M
    Mitsumoto, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 198 (1-2) : 17 - 19
  • [37] Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis
    Hosler, BA
    Nicholson, GA
    Sapp, PC
    Chin, W
    Orrell, RW
    DeBelleroche, JS
    Esteban, J
    Hayward, LJ
    McKennaYasek, D
    Yeung, L
    Cherryson, AK
    Dench, JE
    Wilton, SD
    Laing, NG
    Horvitz, HR
    Brown, RH
    NEUROMUSCULAR DISORDERS, 1996, 6 (05) : 361 - 366
  • [38] Release of copper lens from the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants
    Eum, WS
    Kang, JH
    MOLECULES AND CELLS, 1999, 9 (01) : 110 - 114
  • [39] Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis
    Alvarez-Zaldiernas, Cristina
    Lu, Jun
    Zheng, Yujuan
    Yang, Hongqian
    Blasi, Juan
    Solsona, Carles
    Holmgren, Arne
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (33) : 17197 - 17208
  • [40] Changes in mitochondrial protein expression attributable to the presence of mutant superoxide dismutase 1 (SOD1) in a cell-culture model of SOD1 familial amyotrophic lateral sclerosis (FALS)
    Wood-Allum, CA
    Allen, S
    Shaw, PJ
    NEUROLOGY, 2004, 62 (07) : A186 - A186